Evaluation of prevalent and incident ovarian cancer co-morbidity

British Journal of Cancer

Volumn 106, Issue 11, 2012, Pages 1860-1865

  Stalberg K ^a   Svensson, T ^b   Granath, F ^b   Kieler, H ^b   Tholander, B ^c   Lonn S ^b,d  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d Research and Development at Scania Technical Centre   (Sweden)

Author keywords

co morbidity; epidemiology; ovarian cancer

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; EPITHELIUM TUMOR; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERTENSION; ILEUS; INTESTINE PERFORATION; LIVER DISEASE; MAJOR CLINICAL STUDY; MORBIDITY; NEUTROPENIA; OVARY CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; SURVIVAL RATE; SWEDEN; THROMBOCYTOPENIA; THROMBOEMBOLISM; THYROID DISEASE;

ADULT; AGED; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; OVARIAN NEOPLASMS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; SWEDEN;

EID: 84861459674     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.164     Document Type: Article

References (23)

1. Assimes TL, Suissa S (2009) Age at incident treatment of hypertension and risk of cancer: a population study. Cancer Causes Control 20(10):1811-1820
2. Bankhead CR, Kehoe ST, Austoker J (2005) Symptoms associated with diagnosis of ovarian cancer: a systematic review. BJOG 112: 857-865 (Pubitemid 40896949)
3. Barlow L, Westergren K, Holmberg L, Talback M (2009) The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48: 27-33
4. Bjorge T, Engeland A, Hansen S, Trope CG (1998) Prognosis of patients with ovarian cancer and borderline tumours diagnosed in Norway between 1954 and 1993. Int J Cancer 75: 663-670 (Pubitemid 28145810)
5. Clovenzzz NG, Manetta A, Berman ML, Kohler MF, DiSaia PJ (1999) Management of ovarian cancer in patients older than 80 years of age. Gynecol Oncol 73: 137-139 (Pubitemid 29177613)
6. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. a critical review of available methods. J Clin Epidemiol 56: 221-229 (Pubitemid 36513483)
7. Elit LM, Bondy SJ, Paszat LP, Holowaty EJ, Thomas GM, Stukel TA, Levine MN (2008) Surgical outcomes in women with ovarian cancer. Can J Surg 51: 346-354
8. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff Marianne L., Klint Å, Køtlum Jóanis E., Ólafsdóttir Elínborg, Pukkala E, Storm HH (2010) NORDCAN: Cancer Incidence, Mortality, Prevalence and Prediction in the Nordic Countries. Danish Cancer Society. Available at http://www.ancr.nu
9. Fader AN, von Gruenigen V, Gibbons H, Abushahin F, Starks D, Markman M, Belinson J, Rose P (2008) Improved tolerance of primary chemotherapy with reduced-dose carboplatin and paclitaxel in elderly ovarian cancer patients. Gynecol Oncol 109: 33-38
10. Grossman E, Messerli FH, Boyko V, Goldbourt U (2002) Is there an association between hypertension and cancer mortality? Am J Med 112: 479-486 (Pubitemid 34450709)
11. Hemminki K, Li X, Sundquist J, Sundquist K (2010) Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15: 548-555
12. Hippisley-Cox J, Coupland C (2012) Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. BMJ 344: d8009
13. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166: 1871-1877 (Pubitemid 44455170)
14. Jensen KE, Hannibal CG, Nielsen A, Jensen A, Nohr B, Munk C, Kjaer SK (2008) Social inequality and incidence of and survival from cancer of the female genital organs in a population-based study in Denmark, 1994-2003. Eur J Cancer 44: 2003-2017
15. Klint A, Tryggvadottir L, Bray F, Gislum M, Hakulinen T, Storm HH, Engholm G (2010) Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 49: 632-643
16. Largent JA, Bernstein L, Horn-Ross PL, Marshall SF, Neuhausen S, Reynolds P, Ursin G, Zell JA, Ziogas A, Anton-Culver H (2010) Hypertension, antihypertensive medication use, and breast cancer risk in the California Teachers Study cohort. Cancer Causes Control 21: 1615-1624
17. Mousavi SM, Sundquist K, Hemminki K (2011) Morbidity and mortality in gynecological cancers among first- and second-generation immigrants in Sweden. Int J Cancer; e-pub ahead of print 26 August 2011; doi:1.1002/ijc.26395
18. Nurgalieva Z, Liu CC, Du XL (2010) Chemotherapy use and risk of bone marrow suppression in a large population-based cohort of older women with breast and ovarian cancer. Med Oncol 28(3): 716-725
19. Peeters PH, van Noord PA, Hoes AW, Grobbee DE (1998) Hypertension, antihypertensive drugs, and mortality from cancer among women. J Hypertens 16: 941-947 (Pubitemid 28367948)
20. Stewart S, Ekman I, Ekman T, Oden A, Rosengren A (2010) Population impact of heart failure and the most common forms of cancer: a study of 1 162 309 hospital cases in Sweden (1988 to 2004). Circ Cardiovasc Qual Outcomes 3: 573-580
21. Storm HH, Engholm G, Hakulinen T, Tryggvadottir L, Klint A, Gislum M, Kejs AM, Bray F (2010) Survival of patients diagnosed with cancer in the Nordic countries up to 1999-2003 followed to the end of 2006. A critical overview of the results. Acta Oncol 49: 532-544
22. Swerdlow AJ, Laing SP, Qiao Z, Slater SD, Burden AC, Botha JL, Waugh NR, Morris AD, Gatling W, Gale EA, Patterson CC, Keen H (2005) Cancer incidence and mortality in patients with insulin-treated diabetes: a UK cohort study. Br J Cancer 92: 2070-2075 (Pubitemid 40897432)
23. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population-based analysis. Int J Cancer 120: 1986-1992 (Pubitemid 46418378)